Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
- Conditions
- Crohn Disease (CD)Ulcerative Colitis (UC)IBD (Inflammatory Bowel Disease)
- Registration Number
- NCT07166588
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
- Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring.
Exclusion Criteria
- Patients diagnosed with cancer or with a history of cancer treatment.
- Participation may be restricted at the discretion of the medical team.
- Infants and young children under the age of 10.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prediction model in the patients with inflammatory bowel disease for treatment response From enrollment to the end of treatment at 12 weeks Development of a prognostic prediction model for patients with inflammatory bowel disease and a predictive model for therapeutic response to biologic agents and small molecule therapies
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Seoul National University Hospital
🇰🇷Seoul, Seoul, South Korea
Seoul National University Hospital🇰🇷Seoul, Seoul, South Korea